Alcidion Group Ltd
ASX:ALC

Watchlist Manager
Alcidion Group Ltd Logo
Alcidion Group Ltd
ASX:ALC
Watchlist
Price: 0.064 AUD -3.03% Market Closed
Market Cap: 85.9m AUD
Have any thoughts about
Alcidion Group Ltd?
Write Note

Alcidion Group Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Alcidion Group Ltd
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Alcidion Group Ltd
ASX:ALC
Revenue
AU$37.1m
CAGR 3-Years
13%
CAGR 5-Years
17%
CAGR 10-Years
76%
4DMedical Ltd
ASX:4DX
Revenue
AU$3.8m
CAGR 3-Years
159%
CAGR 5-Years
40%
CAGR 10-Years
N/A
CogState Ltd
ASX:CGS
Revenue
$43.4m
CAGR 3-Years
10%
CAGR 5-Years
15%
CAGR 10-Years
15%
Pro Medicus Ltd
ASX:PME
Revenue
AU$166.3m
CAGR 3-Years
35%
CAGR 5-Years
27%
CAGR 10-Years
28%
Medibio Ltd
ASX:MEB
Revenue
AU$963.8k
CAGR 3-Years
1%
CAGR 5-Years
-18%
CAGR 10-Years
N/A
Medadvisor Ltd
ASX:MDR
Revenue
AU$122.1m
CAGR 3-Years
45%
CAGR 5-Years
68%
CAGR 10-Years
130%
No Stocks Found

Alcidion Group Ltd
Glance View

Market Cap
85.9m AUD
Industry
Health Care

Alcidion Group Ltd. provides intelligent health informatics technology that empowers healthcare professionals with clinical decision support systems to ensure the quality of care for the patients. The company is headquartered in Melbourne, Victoria. The company went IPO on 2011-06-24. The company is engaged in development, licensing and reselling its healthcare software products through its strategic partners. The company also delivers product implementation, product support and maintenance, systems integration and data analysis services to healthcare customers in Australia, New Zealand and the United Kingdom. The Company’s healthcare software products include Miya, Patientrack, Smartpage and ExtraMed. Miya Precision is a clinical solution based on a FHIR-event platform that facilitates multiple clinical and operational applications. Smartpage is a smartphone and Web-based system for hospital communication and task management provides solution to both clinical and non-clinical users. Patientrack is a solution that supports the capture of that data at the bedside, whether directly entered on a tablet or integrated from patient monitors. Its clinical solutions use digital technology.

ALC Intrinsic Value
0.065 AUD
Undervaluation 2%
Intrinsic Value
Price

See Also

What is Alcidion Group Ltd's Revenue?
Revenue
37.1m AUD

Based on the financial report for Jun 30, 2024, Alcidion Group Ltd's Revenue amounts to 37.1m AUD.

What is Alcidion Group Ltd's Revenue growth rate?
Revenue CAGR 10Y
76%

Over the last year, the Revenue growth was -8%. The average annual Revenue growth rates for Alcidion Group Ltd have been 13% over the past three years , 17% over the past five years , and 76% over the past ten years .

Back to Top